<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The metaplastic columnar epithelium in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> has malignant potential </plain></SENT>
<SENT sid="1" pm="."><plain>AIM: To determine whether decreasing <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> leads to regression of Barrett's epithelium </plain></SENT>
<SENT sid="2" pm="."><plain>METHOD: Twenty-four patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> were treated with <z:chebi fb="14" ids="7772">omeprazole</z:chebi> 20 mg o.m. in an open, prospective study; 11 were treated for 12 months, and 13 for 24 months </plain></SENT>
<SENT sid="3" pm="."><plain>Another group of 17 patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> was treated with an <z:chebi fb="0" ids="37961">H2-receptor antagonist</z:chebi> in standard dosage for 12-36 (mean 23) months </plain></SENT>
<SENT sid="4" pm="."><plain>Patients were assessed endoscopically </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: No evidence of significant shortening of the length of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> was seen in any patient treated for 12 or 24 months with <z:chebi fb="14" ids="7772">omeprazole</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Similarly, no shortening of the length of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> was seen in any patient treated with an <z:chebi fb="0" ids="37961">H2-receptor antagonist</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>However, 6 of 11 patients treated with <z:chebi fb="14" ids="7772">omeprazole</z:chebi> for 12 months, and 7 of 13 treated for 24 months, developed macroscopic squamous islands visible below the squamo-columnar junction </plain></SENT>
<SENT sid="8" pm="."><plain>This was not seen in any patient treated with an <z:chebi fb="0" ids="37961">H2-receptor antagonist</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Although there can be reappearance of squamous epithelium in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> of some patients during treatment with <z:chebi fb="14" ids="7772">omeprazole</z:chebi> 20 mg o.m. over 12-24 months, a significant shortening of the columnar lined segment is not seen </plain></SENT>
</text></document>